| Prevalence and characteristics of nonalcoholic fatty liver disease and fibrosis in people living with HIV monoinfection: a systematic review and meta-analysis M Kalligeros, A Vassilopoulos, F Shehadeh, S Vassilopoulos, I Lazaridou, ... Clinical Gastroenterology and Hepatology 21 (7), 1708-1722, 2023 | 29 | 2023 |
| Prevalence of steatotic liver disease (MASLD, MetALD, and ALD) in the United States: NHANES 2017–2020 M Kalligeros, A Vassilopoulos, S Vassilopoulos, DW Victor, E Mylonakis, ... Clinical Gastroenterology and Hepatology 22 (6), 1330-1332. e4, 2024 | 16 | 2024 |
| Cumulative incidence and relative risk of infection in patients with multiple myeloma treated with anti-CD38 monoclonal antibody-based regimens: a systematic review and meta … S Vassilopoulos, A Vassilopoulos, M Kalligeros, F Shehadeh, ... Open Forum Infectious Diseases 9 (11), ofac574, 2022 | 12 | 2022 |
| Avenues for antifungal drug discovery and development: where to now? S Vassilopoulos, E Mylonakis Expert Opinion on Drug Discovery 17 (7), 667-672, 2022 | 10 | 2022 |
| Incidence of serious infections in patients with ANCA-associated vasculitis receiving immunosuppressive therapy: a systematic review and meta-analysis A Vassilopoulos, S Vassilopoulos, M Kalligeros, F Shehadeh, ... Frontiers in Medicine 10, 1110548, 2023 | 6 | 2023 |
| Targeted therapies in CLL/SLL and the cumulative incidence of infection: A systematic review and meta-analysis S Vassilopoulos, F Shehadeh, M Kalligeros, QL Tran, F Schiffman, ... Frontiers in Pharmacology 13, 989830, 2022 | 5 | 2022 |
| Prevalence and risk factors of nonalcoholic fatty liver disease, high-risk nonalcoholic steatohepatitis, and fibrosis among lean United States adults: NHANES 2017-2020 M Kalligeros, S Vassilopoulos, A Vassilopoulos, F Shehadeh, I Lazaridou, ... Annals of Gastroenterology 36 (6), 670, 2023 | 2 | 2023 |
| Risk of infection in patients with hidradenitis suppurativa on biologics or other immunomodulators: a systematic review and meta‐analysis I Lazaridou, A Vassilopoulos, S Vassilopoulos, F Shehadeh, M Kalligeros, ... International Journal of Dermatology 63 (2), 139-149, 2024 | 1 | 2024 |
| Impact of prior HBV, HAV, and HEV infection on non‐alcoholic fatty liver disease S Vassilopoulos, M Kalligeros, A Vassilopoulos, F Shehadeh, G Benitez, ... Journal of Viral Hepatitis 30 (8), 685-693, 2023 | 1 | 2023 |
| Temporal trends and characteristics associated with racial, ethnic, and sex representation in COVID-19 clinical trials: A systematic review and meta-analysis M Kaczynski, A Vassilopoulos, S Vassilopoulos, A Sisti, G Benitez, ... Contemporary Clinical Trials, 107578, 2024 | | 2024 |
| Risk of Infection in Patients With Inflammatory Bowel Disease Treated With Interleukin-Targeting Agents: A Systematic Review and Meta-Analysis K Ouranos, H Saleem, S Vassilopoulos, A Vassilopoulos, EK Mylona, ... Inflammatory Bowel Diseases, izae031, 2024 | | 2024 |
| Prevalence of Steatotic Liver Disease Among US Adults with Rheumatoid Arthritis A Vassilopoulos, M Kalligeros, S Vassilopoulos, F Shehadeh, G Benitez, ... Digestive Diseases and Sciences 69 (3), 989-1003, 2024 | | 2024 |
| Cumulative incidence and mortality rate of cardiovascular complications due to laboratory‐confirmed influenza virus infection: A systematic review and meta‐analysis K Ouranos, S Vassilopoulos, A Vassilopoulos, F Shehadeh, E Mylonakis Reviews in Medical Virology 34 (1), e2497, 2024 | | 2024 |
| 2509. Association of Non-Alcoholic Fatty Liver Disease with HBV, HAV, and HEV Exposure S Vassilopoulos, A Vassilopoulos, G Benitez, M Kaczynski, F Shehadeh, ... Open Forum Infectious Diseases 10 (Supplement_2), ofad500. 2127, 2023 | | 2023 |
| Role of Pneumocystis Jirovecii Pneumonia Prophylaxis with TrimethoprimSulfamethoxazole Among Patients with Autoimmune Inflammatory Diseases Receiving High-Dose Glucocorticoids … A Vassilopoulos, S Vassilopoulos, F Shehadeh, M Kalligeros, ... ARTHRITIS & RHEUMATOLOGY 75, 398-400, 2023 | | 2023 |
| PREVALENCE OF NON-ALCOHOLIC FATTY LIVER DISEASE, HIGH-RISK NON-ALCOHOLIC STEATOHEPATITIS, AND LIVER FIBROSIS IN PATIENTS WITH OSTEOARTHRITIS M Kalligeros, A Vassilopoulos, S Vassilopoulos, JR Wands, K Promrat HEPATOLOGY 78, S1034-S1035, 2023 | | 2023 |
| S1377 Prevalence and Risk Factors of NAFLD, High-Risk NASH, and Fibrosis Among Lean US Adults M Kalligeros, S Vassilopoulos, A Vassilopoulos, F Shehadeh, I Lazaridou, ... Official journal of the American College of Gastroenterology| ACG 118 (10S …, 2023 | | 2023 |
| CLL-105 Cumulative Incidence of Grade 3 or Higher Infections in Patients With CLL/SLL Treated With BTKi-Based Regimens S Vassilopoulos, QL Tran, M Kalligeros, F Shehadeh, E Mylonakis Clinical Lymphoma Myeloma and Leukemia 22, S264, 2022 | | 2022 |
Eleftherios MylonakisHouston Methodist Hospital在 houstonmethodist.org 的电子邮件经过验证
